Envoy Medical
COCH
89 hedge funds and large institutions have $331M invested in Envoy Medical in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 4 closing their positions.
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
67% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 9
6% more funds holding
Funds holding: 84 → 89 (+5)
3.61% more ownership
Funds ownership: 76.99% → 80.61% (+3.6%)
4% more capital invested
Capital invested by funds: $319M → $331M (+$11.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$4.61M |
| 2 |
Parallax Volatility Advisers
San Francisco,
California
|
+$3.77M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$3.11M |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$2.11M |
| 5 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$1.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EH
EMG Holdings
Old Greenwich,
Connecticut
|
-$2.18M |
| 2 |
AC
Athanor Capital
New York
|
-$1.7M |
| 3 |
JP Morgan Chase
New York
|
-$452K |
| 4 |
GH
GAM Holding
Zurich,
Switzerland
|
-$397K |
| 5 |
FTCM
Fir Tree Capital Management
New York
|
-$311K |
COCH Hedge Fund Activity: Q2 2022 in Review
89 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q2 2022, worth a combined $331M — up 3.6% from $319M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new COCH positions and 4 closed out — a net gain of 5 holders — while 15 added to existing stakes and 9 trimmed.
The largest buyer was UBS O'Connor, opening a new position worth an estimated $4.61M. The largest seller was EMG Holdings, exiting entirely with an estimated $2.18M sold.
- 89 institutional investors held Envoy Medical (COCH) as of Q2 2022, up from 84 in Q1 2022.
- Funds reported $331M of Envoy Medical stock for Q2 2022, up 3.6% quarter-over-quarter.
- 9 funds opened new Envoy Medical positions in Q2 2022 and 4 closed out, a net change of +5 holders.
- The largest Envoy Medical buyer in Q2 2022 was UBS O'Connor, an estimated $4.61M added.
- The largest Envoy Medical seller in Q2 2022 was EMG Holdings, an estimated $2.18M sold.
Based on aggregated 13F filings for Q2 2022.